{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "marketState": "CLOSED", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "esgPopulated": false, "regularMarketChangePercent": -0.52588344, "regularMarketPrice": 78.5, "exchange": "LSE", "shortName": "AXSOME THERAPEUTICS INC AXSOME ", "longName": "Axsome Therapeutics, Inc.", "messageBoardId": "finmb_241907563", "exchangeTimezoneName": "Europe/London", "market": "gb_market", "regularMarketTime": 1683914176, "regularMarketDayHigh": 78.9155, "regularMarketDayRange": "78.5 - 78.9155", "regularMarketDayLow": 78.5, "regularMarketVolume": 200, "regularMarketPreviousClose": 78.915, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "LSE", "financialCurrency": "USD", "regularMarketOpen": 78.9155, "averageDailyVolume3Month": 585, "averageDailyVolume10Day": 661, "fiftyTwoWeekLowChange": 56.452, "fiftyTwoWeekLowChangePercent": 2.5604136, "fiftyTwoWeekRange": "22.048 - 82.445", "fiftyTwoWeekHighChange": -3.9449997, "fiftyTwoWeekHighChangePercent": -0.04785008, "fiftyTwoWeekLow": 22.048, "fiftyTwoWeekHigh": 82.445, "earningsTimestamp": 1683547200, "earningsTimestampStart": 1691411400, "earningsTimestampEnd": 1691757000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.72, "sharesOutstanding": 29813200, "bookValue": 2.568, "fiftyDayAverage": 66.45079, "fiftyDayAverageChange": 12.04921, "fiftyDayAverageChangePercent": 0.1813253, "twoHundredDayAverage": 57.526333, "twoHundredDayAverageChange": 20.973667, "twoHundredDayAverageChangePercent": 0.36459246, "marketCap": 25378266, "priceToBook": 30.568535, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1517212800000, "priceHint": 2, "regularMarketChange": -0.41500092, "symbol": "0HKF.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "22 Cortlandt Street", "address2": "16th Floor", "city": "New York", "state": "NY", "zip": "10007", "country": "United States", "phone": "212 332 3241", "fax": "212 320 0245", "website": "https://www.axsome.com", "industry": "", "sector": "", "longBusinessSummary": "Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that is in Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial of for treating attention-deficit/hyperactivity disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.", "fullTimeEmployees": 383, "companyOfficers": [{"maxAge": 1, "name": "Dr. Herriot  Tabuteau M.D.", "age": 54, "title": "Founder, Chairman, CEO & Pres", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 1320968, "fmt": "1.32M", "longFmt": "1,320,968"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 87923912, "fmt": "87.92M", "longFmt": "87,923,912"}}, {"maxAge": 1, "name": "Mr. Nick  Pizzie CPA, M.B.A.", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 732941, "fmt": "732.94k", "longFmt": "732,941"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 17865770, "fmt": "17.87M", "longFmt": "17,865,770"}}, {"maxAge": 1, "name": "Mr. Mark L. Jacobson", "age": 39, "title": "COO & Sec.", "yearBorn": 1983, "fiscalYear": 2022, "totalPay": {"raw": 784661, "fmt": "784.66k", "longFmt": "784,661"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 28273134, "fmt": "28.27M", "longFmt": "28,273,134"}}, {"maxAge": 1, "name": "Mr. Hunter  Murdock Esq.", "age": 42, "title": "Gen. Counsel & Sec.", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": {"raw": 735388, "fmt": "735.39k", "longFmt": "735,388"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 909595, "fmt": "909.6k", "longFmt": "909,595"}}, {"maxAge": 1, "name": "Dr. Amanda  Jones Pharm.D.", "age": 39, "title": "Sr. VP of Clinical Devel.", "yearBorn": 1983, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Lori  Englebert M.B.A.", "age": 44, "title": "Exec. VP of Commercial & Bus. Devel.", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kevin  Laliberte Pharm.D.", "age": 44, "title": "Exec. VP of Product Strategy", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Joseph  Debrah-Afful CPA, M.B.A.", "title": "Director of Fin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}